secwatch.observer — SEC 8-K summary
======================================

Issuer:     MiNK Therapeutics, Inc. (INKT)
CIK:        0001840229
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0000950170-24-074233
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

MiNK Therapeutics stockholders elect directors, ratify KPMG at 2024 annual meeting
--------------------------------------------------------------------------------

- Annual meeting held June 12, 2024; 28,359,271 shares (81.71%) present or represented.
- Brian Corvese and Peter Behner elected as Class III directors for three-year terms.
- Ratification of KPMG LLP as independent auditor for FY2024 approved with 28,242,636 votes for.
- Broker non-votes of 3,364,923 on director elections and none on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840229/000095017024074233/0000950170-24-074233-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840229/000095017024074233/inkt-20240612.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-074233

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer